Gene description for EEF1A1P5 |
Gene name |
eukaryotic translation elongation factor 1 alpha 1 pseudogene 5 |
Gene symbol |
EEF1A1P5 |
Other names/aliases |
EEF1AL3 |
Species |
Homo sapiens |
Database cross references - EEF1A1P5 |
Vesiclepedia |
VP_158078 |
ExoCarta |
ExoCarta_158078 |
Entrez Gene |
158078 |
HGNC |
3200 |
EEF1A1P5 identified in extracellular vesicles derived from the following tissue/cell type |
Ascites [Microvesicles] More >>>
|
21630462
|
Ascites [Microvesicles] More >>>
|
21630462
|
Ascites [Microvesicles] More >>>
|
21630462
|
B cells [Microparticles] More >>>
|
16342139
|
Colorectal cancer cells [Exosomes] More >>>
|
17956143
|
Glioblastoma cells [Microvesicles] More >>>
|
19011622
|
T cells [Microparticles] More >>>
|
16342139
|
T cells [Microparticles] More >>>
|
16342139
|
Experiment description of studies that identified EEF1A1P5 in extracellular vesicles |
1
|
Experiment ID | 157 |
Identified molecule | protein
|
Extracellular vesicle type | Microvesicles |
Identification method | Mass spectrometry [LTQ]
|
PubMed ID |
21630462
|
Organism | Homo sapiens |
Experiment description | Proteomic analysis of microvesicles derived from human colorectal cancer ascites |
Authors | Choi DS, Park JO, Jang SC, Yoon YJ, Jung JW, Choi DY, Kim JW, Kang JS, Park J, Hwang D, Lee KH, Park SH, Kim YK, Desiderio DM, Kim KP, Gho YS |
Journal name |
Proteomics
|
Publication year | 2011 |
Sample | Ascites |
Sample name | Malignant ascites - Colorectal cancer patient 1 |
Isolation/purification methods | Differential centrifugation Sucrose density gradient OptiPrep density gradient |
Flotation density | 1.09 g/mL |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry [LTQ] |
EV-TRACK |
EV110017: EV-METRIC:38%
|
|
|
2
|
Experiment ID | 158 |
Identified molecule | protein
|
Extracellular vesicle type | Microvesicles |
Identification method | Mass spectrometry [LTQ]
|
PubMed ID |
21630462
|
Organism | Homo sapiens |
Experiment description | Proteomic analysis of microvesicles derived from human colorectal cancer ascites |
Authors | Choi DS, Park JO, Jang SC, Yoon YJ, Jung JW, Choi DY, Kim JW, Kang JS, Park J, Hwang D, Lee KH, Park SH, Kim YK, Desiderio DM, Kim KP, Gho YS |
Journal name |
Proteomics
|
Publication year | 2011 |
Sample | Ascites |
Sample name | Malignant ascites - Colorectal cancer patient 2 |
Isolation/purification methods | Differential centrifugation Sucrose density gradient OptiPrep density gradient |
Flotation density | 1.09 g/mL |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry [LTQ] |
EV-TRACK |
EV110017: EV-METRIC:38%
|
|
|
3
|
Experiment ID | 159 |
Identified molecule | protein
|
Extracellular vesicle type | Microvesicles |
Identification method | Mass spectrometry [LTQ]
|
PubMed ID |
21630462
|
Organism | Homo sapiens |
Experiment description | Proteomic analysis of microvesicles derived from human colorectal cancer ascites |
Authors | Choi DS, Park JO, Jang SC, Yoon YJ, Jung JW, Choi DY, Kim JW, Kang JS, Park J, Hwang D, Lee KH, Park SH, Kim YK, Desiderio DM, Kim KP, Gho YS |
Journal name |
Proteomics
|
Publication year | 2011 |
Sample | Ascites |
Sample name | Malignant ascites - Colorectal cancer patient 3 |
Isolation/purification methods | Differential centrifugation Sucrose density gradient OptiPrep density gradient |
Flotation density | 1.09 g/mL |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry [LTQ] |
EV-TRACK |
EV110017: EV-METRIC:38%
|
|
|
4
|
Experiment ID | 308 |
Identified molecule | protein
|
Extracellular vesicle type | Microparticles |
Identification method | Mass spectrometry [MALDI TOF/TOF] Mass spectrometry [Q-TOF]
|
PubMed ID |
16342139
|
Organism | Homo sapiens |
Experiment description | Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization |
Authors | Miguet L, Pacaud K, Felden C, Hugel B, Martinez MC, Freyssinet JM, Herbrecht R, Potier N, van Dorsselaer A, Mauvieux L |
Journal name |
Proteomics
|
Publication year | 2006 |
Sample | B cells |
Sample name | B cells - Chronic B cell lymphoid patient |
Isolation/purification methods | Differential centrifugation |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry [MALDI TOF/TOF] Mass spectrometry [QTOF] |
EV-TRACK |
-
|
|
|
5
|
Experiment ID | 20 |
Identified molecule | protein
|
Extracellular vesicle type | Exosomes |
Identification method | Mass spectrometry
|
PubMed ID |
17956143
|
Organism | Homo sapiens |
Experiment description | Proteomic analysis of microvesicles derived from human colorectal cancer cells. |
Authors | Choi DS, Lee JM, Park GW, Lim HW, Bang JY, Kim YK, Kwon KH, Kwon HJ, Kim KP, Gho YS |
Journal name |
JPR
|
Publication year | 2007 |
Sample | Colorectal cancer cells |
Sample name | HT29 |
Isolation/purification methods | Differential centrifugation Sucrose density gradient Diafiltration |
Flotation density | 1.16 g/mL |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry [LTQ] Western blotting |
EV-TRACK |
-
|
|
|
6
|
Experiment ID | 203 |
Identified molecule | mrna
|
Extracellular vesicle type | Microvesicles |
Identification method | Microarray
|
PubMed ID |
19011622
|
Organism | Homo sapiens |
Experiment description | Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers |
Authors | Skog J, Wüer T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky AM, Breakefield XO |
Journal name |
Nat Cell Biol
|
Publication year | 2008 |
Sample | Glioblastoma cells |
Sample name | Glioblastoma cells |
Isolation/purification methods | Differential centrifugation Ultracentrifugation Filtration |
Flotation density | - |
Molecules identified in the study | Protein miRNA mRNA |
Methods used in the study | RT-PCR Antibody array Microarray |
EV-TRACK |
-
|
|
|
7
|
Experiment ID | 306 |
Identified molecule | protein
|
Extracellular vesicle type | Microparticles |
Identification method | Mass spectrometry [MALDI TOF/TOF] Mass spectrometry [Q-TOF]
|
PubMed ID |
16342139
|
Organism | Homo sapiens |
Experiment description | Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization |
Authors | Miguet L, Pacaud K, Felden C, Hugel B, Martinez MC, Freyssinet JM, Herbrecht R, Potier N, van Dorsselaer A, Mauvieux L |
Journal name |
Proteomics
|
Publication year | 2006 |
Sample | T cells |
Sample name | CEM T cell - PHA activation |
Isolation/purification methods | Differential centrifugation |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry [MALDI TOF/TOF] Mass spectrometry [QTOF] |
EV-TRACK |
-
|
|
|
8
|
Experiment ID | 307 |
Identified molecule | protein
|
Extracellular vesicle type | Microparticles |
Identification method | Mass spectrometry [MALDI TOF/TOF] Mass spectrometry [Q-TOF]
|
PubMed ID |
16342139
|
Organism | Homo sapiens |
Experiment description | Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization |
Authors | Miguet L, Pacaud K, Felden C, Hugel B, Martinez MC, Freyssinet JM, Herbrecht R, Potier N, van Dorsselaer A, Mauvieux L |
Journal name |
Proteomics
|
Publication year | 2006 |
Sample | T cells |
Sample name | CEM T cell - ActD activation |
Isolation/purification methods | Differential centrifugation |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry [MALDI TOF/TOF] Mass spectrometry [QTOF] |
EV-TRACK |
-
|
|
|